duloxetine hydrochloride has been researched along with Neuralgia in 122 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (7.38) | 29.6817 |
| 2010's | 73 (59.84) | 24.3611 |
| 2020's | 40 (32.79) | 2.80 |
| Authors | Studies |
|---|---|
| Can, U; Derle, E | 1 |
| Makino, J; Mitsuboshi, S; Neo, M; Nishihara, M; Suzuki, K; Yamada, T | 1 |
| Ammitzbøll, N; Arendt-Nielsen, L; Bertoli, D; Brock, C; Drewes, AM; Kappel, A; Olesen, AE; Petersen, KK | 1 |
| Agar, M; Allcroft, P; Ariyoshi, K; Brown, L; Clark, K; Currow, DC; Fazekas, B; Fujiwara, N; Hasuo, H; Ishiki, H; Iwase, S; Kochovska, S; Koyama, A; Le, B; Lee, J; Lovell, M; Matsuda, Y; Matsuoka, H; Miyaji, T; Oyamada, S; Phillips, J; Satomi, E; Yamaguchi, T | 1 |
| Feng, S; Mao, M; Wang, J; Wang, X; Zhang, S; Zhou, F | 1 |
| Cui, J; Jiang, L; Xiong, Y | 1 |
| Akpinar, P; Aktas, I; Atici, A; Begoglu, FA; Illeez, OG; Kaysin, MY; Nazligül, T; Oktay, KNK; Ozkan, FU | 1 |
| Honjoh, K; Kubota, A; Matsumine, A; Nakajima, H; Watanabe, S | 1 |
| Baig, MU; Madden, K; Moody, K | 1 |
| Liu, X; Lu, Y; Qiu, S; Wang, M; Xu, R; Yan, M; Yang, C; Zhang, L; Zhang, P; Zhu, J | 1 |
| Ahmed, SH; Alam, U; Bennett, DL; Bouhassira, D; Bradburn, M; Cooper, C; Devers, M; Gandhi, R; Glover, R; Gouni, R; Hariman, C; Horspool, M; Johnson, M; Jude, EB; Julious, S; Loban, A; Maguire, D; McDougall, C; Petrie, J; Rajbhandari, S; Rayman, G; Rice, ASC; Selvarajah, D; Sharma, S; Sloan, G; Sutherland, K; Tesfaye, S; Tsatlidis, V; Turton, E; Vas, P; Waterhouse, S; White, D | 1 |
| Capon, C; Crevant, A; Moreau, N; Pointin, A; Sulukdjian, A | 1 |
| Benoliel, R; Eliav, E; Khan, J; Korczeniewska, OA; McNeil, R; Ren, Y; Wang, Q | 1 |
| Chen, KY; Li, RY | 1 |
| Alcántara Montero, A; Pacheco de Vasconcelos, SR | 1 |
| Aster, HC; Braun, A; Evdokimov, D; Sommer, C; Üçeyler, N | 1 |
| Ahmed, SH; Alam, U; Bennett, DL; Bouhassira, D; Bradburn, M; Cooper, C; Devers, M; Gandhi, R; Glover, R; Gouni, R; Hariman, C; Horspool, M; Johnson, M; Jude, E; Julious, SA; Loban, A; Maguire, D; McDougall, C; Petrie, J; Rajbhandari, S; Rayman, G; Selvarajah, D; Sharma, S; Sloan, G; Sutherland, K; Tesfaye, S; Tsatlidis, V; Turton, E; Vas, P; Waterhouse, S; White, D; Young, T | 1 |
| Chaurasia, RN; Joshi, D; Kumar, A; Mahesh, B; Mishra, VN; Pathak, A; Singh, VK | 1 |
| Ishibashi, T; Koga, K; Sueto, D; Tsuda, M; Yamaura, K; Yoshikawa, Y | 1 |
| Chen, H; Chen, SR; Huang, Y; Pan, HL | 1 |
| Bustos-Quevedo, G; Constandil, L; Hernández, A; Lobos, N; Lux, S; Marcos, JL; Pelissier, T; Zepeda, RJ | 1 |
| McGinn, R; Smith, MA; Zerfas, I | 1 |
| Jang, HN; Oh, TJ | 1 |
| Abdelhamid, S; Russjan, A; Shabani, M; Tarnutzer, AA | 1 |
| Braden, K; Chen, Z; Doyle, TM; Jacobson, KA; Salvemini, D; Samson, WK; Stockstill, K; Tosh, DK; Wahlman, C; Yosten, GL | 1 |
| Ariyoshi, K; Hasegawa, Y; Hasuo, H; Ishiki, H; Iwase, S; Kataoka, Y; Kawaguchi, T; Koyama, A; Matsuda, Y; Matsumoto, Y; Matsuoka, H; Miyaji, T; Morita, T; Nakura, M; Ohtake, Y; Otani, H; Otsuka, M; Oyamada, S; Sakai, K; Sakuma, H; Satomi, E; Tahara, K; Tokoro, A; Tsukuura, H; Yamaguchi, T | 1 |
| Jha, S; Mazumder, A; Sahani, OP; Siddiqui, S; Verma, MK; Waghdhare, S | 1 |
| Alipour, A; Avan, R; Hendouei, N; Janbabaei, G; Salehifar, E; Tabrizi, N | 1 |
| Gül, HL; Gül, ŞK; Tepetam, H | 1 |
| Cader, MZ; Nash, A; Pokhilko, A | 1 |
| Matta, C; Mensah-Nyagan, AG; Meyer, L; Taleb, O | 1 |
| Asaki, T; Fujita, M; Kasai, E; Matsuo, M; Sakurai, Y; Tamano, R; Yoneda, S | 1 |
| Bai, J; Jiang, S; Xia, R; Yan, L | 1 |
| Corradini, L; Imam, MZ; Kuo, A; Nicholson, JR; Smith, MT | 1 |
| Ahmed, A; Ahmed, M; Austin, S; Barboi, A; Barohn, RJ; Bazant, M; Biliciler, S; Brannagan, T; Bril, V; Brown, A; Burns, T; Cash, T; Dimachkie, MM; Gajewski, B; Hayat, G; Hehir, M; Heitzman, D; Herbelin, LL; Hussain, Y; Iyadurai, S; Jacoby, M; Jawdat, O; Karam, C; Kimminau, KS; Kissel, J; Kolb, N; Kushlaf, H; Kutz, C; Ladha, S; Lewis, R; Li, Y; Lou, JS; Mallonee, W; Memon, A; Mudaranthakam, DP; Pascuzzi, R; Pasnoor, M; Pulley, M; Quan, D; Ralph, J; Ramchandren, S; Salajegheh, K; Saperstein, D; Scelsa, S; Sharma, K; Smith, G; Stino, A; Swenson, A; Thaisetthawatkul, P; Tobon, A; Trivedi, J; Twydell, P; Verma, N; Vu, T; Walk, D; Wicklund, M; Wolfe, G; Wymer, J | 1 |
| Bhatia, A; Garg, V; Gulati, M; Kumar, B; Melkani, I; Pandey, NK; Prakash, T; Singh, S; Singh, SK | 1 |
| Makino, K; Nakamura, T; Suzuki, Y; Takahashi, H; Takahashi, Y; Yoshizawa, K | 1 |
| Navratilova, E; Phelps, CE; Porreca, F | 1 |
| Furgała-Wojas, A; Sałat, K; Sałat, R | 1 |
| Barros, CM; Boralli, VB; Costa, LH; Galdino, G; Kawano, T; Placido, RV; Podesta, MHMC; Rodrigues, RF; Santos, RS | 1 |
| Hwang, JA; Kim, DW; Kim, SI; Kwon, HH; Lee, J; Lee, SY; Lee, WH; Park, H; Shin, HJ; Shin, J; Shin, N; Tran, Q | 1 |
| Chen, M; Hoshino, H; Obata, H; Saito, S; Yang, Y | 1 |
| Katz, P; Liedgens, H; Pegoraro, V | 1 |
| Ito, S; Obata, H; Saito, S; Suto, T | 1 |
| Ariyoshi, K; Ishiki, H; Iwase, S; Kawaguchi, T; Kizawa, Y; Koyama, A; Matsuda, Y; Matsuoka, H; Miyaji, T; Morita, T; Yamaguchi, T | 1 |
| Asaki, T; Hasegawa, M; Kasai, E; Minami, K; Oyama, H; Shinohara, S; Tamano, R | 1 |
| Di Cesare Mannelli, L; Farina, C; Ghelardini, C; Maresca, M; Micheli, L; Scherz, MW | 1 |
| Choi, S; Chung, Y; Kim, SK; Kim, W; Min, BI | 1 |
| Ajimi, J; Masuda, R; Murata, T | 1 |
| Amino, H; Beppu, M; Hirano, S; Iimori, T; Isose, S; Kojima, K; Kuwabara, S; Matsumoto, K; Misawa, S; Mukai, H; Nagashima, K; Omori, S; Sato, T; Sekiguchi, Y; Shibuya, K; Suichi, T; Takemoto, M; Uno, T; Watanabe, K; Yokote, K | 1 |
| Badran, DI; Helmy, SA; Tawfik, MK; Zaitone, SA | 1 |
| Hama, A; Hayashi, I; Higo, N; Natsume, T; Ogawa, S; Takamatsu, H | 1 |
| Allen, R; Burke, L; Dworkin, RH; Farrar, JT; Gewandter, JS; Gilron, I; Katz, NP; Markman, JD; Marshall, SF; Patel, KV; Resnick, M; Rice, ASC; Rowbotham, MC; Smith, SM; Turk, DC; Vanhove, GF; Wasan, AD; Zhang, S | 1 |
| Parke, SC; Reyes, MR | 1 |
| Alduntzin, U; Barrot, M; Ceredig, RA; Doridot, S; Gaveriaux-Ruff, C; Massotte, D; Pierre, F; Salvat, E; Yalcin, I | 1 |
| Inoue, K; Tozaki-Saitoh, H; Tsuda, M; Yamashita, T | 1 |
| Alavi, A; Farshchian, N; Heydarheydari, S; Moradian, N | 1 |
| Barrot, M; Ceredig, RA; Chavant, V; Daniel, D; Ernst, C; Gilsbach, R; Goumon, Y; Joganah, LE; Kremer, M; Lacaud, A; Lelievre, V; Lutz, PE; Massotte, D; Megat, S; Nexon, L; Salvat, E; Théroux, JF; Turecki, G; Wurtz, X; Yalcin, I | 1 |
| Ariyoshi, K; Inoue, A; Kizawa, Y; Koyama, A; Matsuoka, H; Oyamada, S; Tagami, K | 1 |
| Awaga, Y; Hama, A; Hayashi, I; Magata, Y; Natsume, T; Ogawa, S; Okamoto, S; Shidahara, Y; Takamatsu, H; Yamoto, K | 1 |
| Anandhakrishnan, NK; Gowthamarajan, K; Gulati, M; Jyoti, J; Kapoor, B; Khursheed, R; Kumar, B; Kumar, R; Melkani, I; Mohanta, S; Narang, R; Pandey, NK; Singh, SK; Som, S; Yadav, AK | 1 |
| Ariyoshi, K; Hasegawa, Y; Hasuo, H; Ishiki, H; Iwase, S; Kataoka, Y; Kawaguchi, T; Koyama, A; Matsuda, Y; Matsumoto, Y; Matsuoka, H; Miyaji, T; Morita, T; Ohtake, Y; Otani, H; Otsuka, M; Oyamada, S; Sakai, K; Sakuma, H; Satomi, E; Shinomiya, T; Tokoro, A; Tsukuura, H; Yamaguchi, T | 1 |
| Ahles, T; Bressler, LR; Cirrincione, C; Fadul, CE; Fleishman, S; Gilman, PB; Knox, C; Le-Lindqwister, N; Pang, H; Paskett, ED; Shapiro, CL; Smith, EM | 1 |
| Silvestri, NJ; Trivedi, JR; Wolfe, GI | 1 |
| Badghisi, H; Meske, DS; Ossipov, MH; Oyarzo, J; Porreca, F; Xie, JY | 1 |
| Dickenson, AH | 1 |
| Hsu, YC; Tzeng, NS | 1 |
| Aoki, T; Enomoto, R; Hamakawa, N; Kakimoto, S; Matsuoka, N; Murai, N; Oe, T; Sekizawa, T; Tamura, S; Tsukamoto, M | 1 |
| Hughes, RA; Lunn, MP; Wiffen, PJ | 1 |
| Aoki, T; Matsuoka, N; Murai, N; Tamura, S; Tsukamoto, M | 1 |
| Castagné, V; Le Cudennec, C | 1 |
| Engel, CC | 1 |
| Bak, K; Bleeker, J; Cavaletti, G; Chauhan, C; Dworkin, RH; Gavin, P; Hershman, DL; Lacchetti, C; Lavino, A; Lavoie Smith, EM; Loprinzi, CL; Lustberg, MB; Paice, J; Schneider, B; Smith, ML; Smith, T; Terstriep, S; Wagner-Johnston, N | 1 |
| Huelin, R; Khankhel, Z; Mould, J; Parker, L; Wasiak, R | 1 |
| Irving, G; Malcolm, S; Raskin, J; Risser, RC; Tanenberg, RJ | 1 |
| Chu, KL; Dart, MJ; Frost, J; Gomez, E; Jarvis, MF; Li, L; McGaraughty, S; Meyer, MD; Xu, J | 1 |
| Bouhassira, D; Choy, E; Cruccu, G; Freynhagen, R; Kosek, E; Lledó, A; Marchettini, P; Micó, JA; Perrot, S; Schacht, A; Skljarevski, V; Spaeth, M; Tesfaye, S; Tölle, T; Wilhelm, S | 1 |
| Chu, SH; Cleeland, CS; Geng, Y; Lee, ES; Lee, YJ; Wang, XS | 1 |
| Dueñas, H; Gao, Y; Gu, L; Guo, X; Han, P; Li, Q; Qu, S; Raskin, J; Skljarevski, V; Wang, CN; Yang, G; Yue, L | 1 |
| Liu, Y; Qian, C; Yang, M | 1 |
| Guy, S; Lam, T; Loh, E; Mehta, S; Teasell, R | 1 |
| Handa, J; Konno, S; Krupkova, O; Sekiguchi, M | 1 |
| Kiss, G | 1 |
| Geroldinger, A; Heinze, G; Kress, HG; Oehmke, MJ; Pramhas, S; Schukro, RP | 1 |
| Allen, J; Cormier, J; Havelin, J; Imbert, I; King, T; Porreca, F | 1 |
| Ekram, AR; Hossain, SM; Hussain, SM | 1 |
| Alghamdi, H; Anwer, MM; Eliav, E; Khan, J; Ziccardi, V | 1 |
| Ceci, A; Doods, H; Hu, B; Treede, RD | 1 |
| Bhatia, A | 1 |
| Mehta, AK; Tripathi, CD; Yadav, AM | 1 |
| Inoue, K; Kohno, K; Kometani, M; Tomiyama, D; Tozaki-Saitoh, H; Tsuda, M; Yamamoto, S; Yamashita, T; Zhang, J | 1 |
| Loprinzi, CL; Majithia, N; Smith, TJ | 1 |
| Cherrier, C; Di Patrizio, P; Poucher, AC; Poucher, M | 1 |
| Alcantara-Montero, A | 1 |
| Heller, S; Schuler, U | 1 |
| Berman, K; Fishbain, D; Kajdasz, DK | 1 |
| Hawley, P | 1 |
| Chappell, AS; Desaiah, D; Detke, MJ; Gross, JL; Skljarevski, V; Zhang, Q; Ziegler, D | 1 |
| Cummons, TA; Harrison, JE; Leventhal, L; Lu, P; Piesla, MJ; Strassle, BW; Whiteside, GT | 1 |
| Esfahani, F; Gomori, A; Grossberndt, A; Intrater, H; Klowak, M; Leong, C; Namaka, M; Turcotte, D | 1 |
| Acharya, N; Crucitti, A; Hall, JA; Oakes, TM; Utterback, BG; Wang, F | 1 |
| Boulanger, L; Chen, S; Fraser, K; Wu, N; Zhao, Y | 1 |
| Jefferies, K | 1 |
| Finnerup, NB | 1 |
| Dijkgraaf, MGW; Heesen, M; Hollmann, MW; Kruis, MR; Pijl, AJ; van der Vegt, MH; Vos, K; Vranken, JH | 1 |
| Budhia, S; Gabriel, Z; Plested, M | 1 |
| Sun, P; Watson, P; Zhao, Y | 1 |
| Courteix, C; Eschalier, A; Fialip, J; Libert, F; Loiodice, S; Privat, AM; Wattiez, AS | 1 |
| Barohn, RJ; Dimachkie, MM; Herbelin, L; Khan, S; McVey, A; Mittal, M; Mummaneni, RB; Pasnoor, M; Ridings, L; Saperstein, D; Wang, Y | 1 |
| Ahl, J; Irving, GA; Malcolm, SK; Risser, RC; Robinson, MJ; Skljarevski, V; Tanenberg, RJ | 1 |
| Anand, KS; Dhikav, V; Prasad, A | 1 |
| Dyhr, H; Erichsen, HK; Hansen, MK; Marcher, L; Munro, G; Sheykhzade, M; Storm, A | 1 |
| Arslanian, A; Best, AE; Duan, RW; Nothaft, W; Pritchett, Y; Rowbotham, MC; Stacey, BR; Zhou, Q | 1 |
| Miyazaki, R; Yamamoto, T | 1 |
| Granot, M; Granovsky, Y; Khamaisi, M; Nahman-Averbuch, H; Yarnitsky, D | 1 |
| Fujisaka, Y; Kaneda, H; Koyama, A; Makimura, C; Matsuoka, H; Nakagawa, K; Okamoto, W; Otsuka, M; Tsurutani, J | 1 |
| Ardid, D; Chapuy, E; Eschalier, A; Grégoire, S; Michaud, V | 1 |
| Lluch Girbés, E; López Cubas, C; Nijs, J; Torres-Cueco, R | 1 |
| D'Souza, DN; Iyengar, S; Pritchett, YL; Raskin, J; Tran, P; Waninger, A; Wernicke, JF | 1 |
| Terneus, W | 1 |
| Chappell, AS; D'Souza, DN; Iyengar, S; Pritchett, YL; Raskin, J; Smith, TR; Wang, F; Wernicke, JF | 1 |
| Backonja, MM; Desaiah, D; Farrar, JT; Fishbain, DA; Iyengar, S; Jensen, TS; Kajdasz, DK; McQuay, HJ; Rowbotham, MC; Sang, CN; Ziegler, D | 1 |
24 review(s) available for duloxetine hydrochloride and Neuralgia
| Article | Year |
|---|---|
Comparison of the Efficacy and Safety of Duloxetine and Gabapentin in Diabetic Peripheral Neuropathic Pain: A Meta-Analysis.
Topics: Analgesics; Chronic Disease; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; Humans; Neuralgia | 2022 |
Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review.
Topics: Amitriptyline; Anticonvulsants; Antidepressive Agents; Carbamazepine; Duloxetine Hydrochloride; Fluoxetine; Gabapentin; Humans; Lamotrigine; Multicenter Studies as Topic; Network Meta-Analysis; Neuralgia; Pregabalin; Randomized Controlled Trials as Topic; Vitamins | 2022 |
Role of vortioxetine in the treatment of neuropathic pain.
Topics: Antidepressive Agents; Chronic Pain; Duloxetine Hydrochloride; Humans; Neuralgia; Vortioxetine | 2022 |
Pharmacologic Management of Cancer-Related Pain in Pregnant Patients.
Topics: Analgesics; Analgesics, Opioid; Cancer Pain; Duloxetine Hydrochloride; Female; Gabapentin; Humans; Neoplasms; Neuralgia; Nociceptive Pain; Pregnancy | 2023 |
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy.
Topics: Capsaicin; Diabetes Mellitus; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neuralgia; Quality of Life; United States | 2023 |
Pharmacotherapy for Neuropathic Pain in Japan.
Topics: Aged; Algorithms; Amines; Analgesics, Opioid; Anticonvulsants; Antidepressive Agents; Cyclohexanecarboxylic Acids; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Japan; Neuralgia; Pain Management; Pregabalin | 2017 |
Gaps in Understanding Mechanism and Lack of Treatments: Potential Use of a Nonhuman Primate Model of Oxaliplatin-Induced Neuropathic Pain.
Topics: Analgesics; Animals; Antineoplastic Agents; Brain; Disease Models, Animal; Duloxetine Hydrochloride; Humans; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Primates | 2018 |
[Green Pharma: A New Strategy for Drug Discovery in Academia by Targeting Glial Cells and ATP Receptors].
Topics: Animals; Disease Models, Animal; Drug Discovery; Duloxetine Hydrochloride; Humans; Hyperalgesia; Injections, Spinal; Molecular Targeted Therapy; Neuralgia; Neuroglia; Purinergic P2X Receptor Antagonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X4 | 2018 |
Treatment of painful peripheral neuropathy.
Topics: Analgesics; Antidepressive Agents; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Neuralgia; Pain Management; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes | 2013 |
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.
Topics: Adult; Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Neuralgia; Randomized Controlled Trials as Topic; Thiophenes | 2014 |
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
Topics: Adult; Amines; Amitriptyline; Analgesics; Anticonvulsants; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Baclofen; Comorbidity; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Duloxetine Hydrochloride; Evidence-Based Medicine; Gabapentin; gamma-Aminobutyric Acid; Gels; Humans; Incidence; Ketamine; Neoplasms; Neuralgia; Peripheral Nervous System Diseases; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Survivors; Thiophenes; Treatment Outcome; United States | 2014 |
A systematic review of pharmacoeconomic studies for pregabalin.
Topics: Amines; Analgesics; Anticonvulsants; Chronic Disease; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Economics, Pharmaceutical; Fibromyalgia; Gabapentin; gamma-Aminobutyric Acid; Health Services; Humans; Neuralgia; Pregabalin; Quality of Life; Quality-Adjusted Life Years; Spain; Sweden; United States | 2015 |
Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.
Topics: Amitriptyline; Anticonvulsants; Antidepressive Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Carbamazepine; Central Nervous System; Cyclohexanols; Duloxetine Hydrochloride; Epothilones; Humans; Neoplasms; Neuralgia; Oxcarbazepine; Peripheral Nervous System Diseases; Pyrazines; Taxoids; Thalidomide; Thiophenes; Venlafaxine Hydrochloride; Vinca Alkaloids | 2015 |
Antidepressants Are Effective in Decreasing Neuropathic Pain After SCI: A Meta-Analysis.
Topics: Amitriptyline; Antidepressive Agents; Databases, Factual; Duloxetine Hydrochloride; Humans; Neuralgia; Praziquantel; Randomized Controlled Trials as Topic; Spinal Cord Injuries | 2015 |
[DRUG THERAPY OF NEUROPATHIC PAIN BASED ON THE LATEST RECOMMENDATIONS].
Topics: Amines; Amitriptyline; Analgesics, Non-Narcotic; Analgesics, Opioid; Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Neuralgia; Practice Guidelines as Topic; Pregabalin; Thiophenes | 2015 |
Duloxetine in Painful Diabetic Neuropathy: A Systematic Review.
Topics: Analgesics; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neuralgia; Randomized Controlled Trials as Topic | 2016 |
New Practical Approaches to Chemotherapy-Induced Neuropathic Pain: Prevention, Assessment, and Treatment.
Topics: Analgesics; Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Neuralgia; Pain Management; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic | 2016 |
[Desvenlafaxine and neuropathic pain: additional clinical benefits of a second generation serotonin-noradrenaline reuptake inhibitor].
Topics: Antidepressive Agents; Biological Availability; Biotransformation; Chronic Pain; Clinical Trials as Topic; Cytochrome P-450 Enzyme System; Depressive Disorder; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Interactions; Duloxetine Hydrochloride; Humans; Multicenter Studies as Topic; Neuralgia; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2017 |
[Chemotherapy-induced peripheral neuropathy and neuropathic pain].
Topics: Antineoplastic Agents; Cryotherapy; Duloxetine Hydrochloride; Humans; Neuralgia; Peripheral Nervous System Diseases; Physical Therapy Modalities; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2017 |
Duloxetine for neuropathic pain based on recent clinical trials.
Topics: Antidepressive Agents; Clinical Trials as Topic; Duloxetine Hydrochloride; Humans; Neuralgia; Thiophenes; Treatment Outcome | 2006 |
A treatment algorithm for neuropathic pain: an update.
Topics: Algorithms; Analgesics; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Neuralgia; Pain Measurement; Paroxetine; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes | 2009 |
Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.
Topics: Adrenergic Uptake Inhibitors; Chronic Disease; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Polypharmacy; Randomized Controlled Trials as Topic; Thiophenes | 2010 |
Treatment of neuropathic pain.
Topics: Antidepressive Agents, Tricyclic; Duloxetine Hydrochloride; Humans; Neuralgia; Peripheral Nervous System Diseases; Thiophenes | 2010 |
Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review.
Topics: Analgesics; Anesthetics, Local; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Lidocaine; Neuralgia; Pregabalin; Thiophenes; Treatment Outcome | 2010 |
27 trial(s) available for duloxetine hydrochloride and Neuralgia
| Article | Year |
|---|---|
A mechanism-based proof of concept study on the effects of duloxetine in patients with painful knee osteoarthritis.
Topics: Duloxetine Hydrochloride; Humans; Neuralgia; Osteoarthritis, Knee; Pain Measurement; Proof of Concept Study; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol.
Topics: Adult; Analgesics, Opioid; Cancer Pain; Clinical Trials, Phase III as Topic; Double-Blind Method; Duloxetine Hydrochloride; Humans; Multicenter Studies as Topic; Neoplasms; Neuralgia; Pregabalin; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
Comparison of the effects of duloxetine and pregabalin on pain and associated factors in patients with knee osteoarthritis.
Topics: Duloxetine Hydrochloride; Humans; Neuralgia; Osteoarthritis, Knee; Pregabalin; Quality of Life; Treatment Outcome | 2022 |
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomise
Topics: Amitriptyline; Analgesics; Cross-Over Studies; Diabetes Mellitus; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Neuralgia; Pregabalin; Treatment Outcome | 2022 |
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
Topics: Adult; Amitriptyline; Cost-Benefit Analysis; Diabetes Mellitus; Duloxetine Hydrochloride; Humans; Neuralgia; Pregabalin; Quality of Life | 2022 |
Efficacy of Duloxetine in Patients with Central Post-stroke Pain: A Randomized Double Blind Placebo Controlled Trial.
Topics: Double-Blind Method; Duloxetine Hydrochloride; Humans; Neuralgia; Pain Measurement; Stroke; Treatment Outcome | 2023 |
Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.
Topics: Adult; Aged; Cancer Pain; Chronic Pain; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Japan; Male; Middle Aged; Neoplasms; Neuralgia; Pain Measurement; Placebos; Prognosis; Treatment Outcome | 2020 |
Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.
Topics: Adult; Analgesics; Breast Neoplasms; Bridged-Ring Compounds; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Neuralgia; Pregabalin; Surveys and Questionnaires; Taxoids; Treatment Outcome | 2020 |
Duloxetine and pregabalin in neuropathic pain of lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Cancer Pain; Duloxetine Hydrochloride; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neuralgia; Pain Measurement; Pregabalin; Prospective Studies; Quality of Life; Treatment Outcome | 2020 |
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.
Topics: Adult; Aged; Analgesics; Bayes Theorem; Comparative Effectiveness Research; Duloxetine Hydrochloride; Female; Humans; Male; Mexiletine; Middle Aged; Neuralgia; Nortriptyline; Pain Management; Polyneuropathies; Pregabalin; Treatment Outcome | 2021 |
Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.
Topics: Adult; Aged; Amines; Analgesics; Analgesics, Opioid; Cancer Pain; Cyclohexanecarboxylic Acids; Double-Blind Method; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Middle Aged; Neoplasms; Neuralgia; Research Design; Young Adult | 2017 |
Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy.
Topics: Antineoplastic Agents; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Peripheral Nervous System Diseases; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2018 |
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Topics: Aged; Analgesics, Opioid; Cancer Pain; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Japan; Male; Middle Aged; Neuralgia; Pain Measurement; Pregabalin; Treatment Outcome | 2019 |
Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Peripheral Nervous System Diseases; Quality of Life; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2013 |
Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.
Topics: Adult; Aged; Aged, 80 and over; Amines; Analgesics; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Pregabalin; Treatment Outcome | 2014 |
Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
Topics: Aged; Aged, 80 and over; Analgesics; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Pregabalin; Severity of Illness Index; Treatment Outcome | 2014 |
Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
Topics: Adult; Aged; Analgesics; China; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Serotonin and Noradrenaline Reuptake Inhibitors; United States | 2015 |
Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component: A Randomized, Double-blind, Placebo-controlled Crossover Trial.
Topics: Analgesics; Chronic Disease; Cross-Over Studies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Low Back Pain; Male; Middle Aged; Neuralgia; Prospective Studies; Treatment Outcome | 2016 |
Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.
Topics: Adrenergic Uptake Inhibitors; Aged; Confidence Intervals; Diabetic Neuropathies; Drug Monitoring; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Thiophenes; Time Factors; Treatment Outcome | 2009 |
Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Disability Evaluation; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Outcome Assessment, Health Care; Pain Measurement; Pain Threshold; Placebo Effect; Spinal Cord Injuries; Stroke; Thiophenes; Treatment Outcome | 2011 |
Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
Topics: Aged; Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Pregabalin; Thiophenes; Treatment Outcome | 2011 |
Efficacy and safety of the α4β2 neuronal nicotinic receptor agonist ABT-894 in patients with diabetic peripheral neuropathic pain.
Topics: Aged; Azabicyclo Compounds; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Nicotinic Agonists; Pain Measurement; Pyridines; Receptors, Nicotinic; Thiophenes; Treatment Outcome | 2012 |
Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy.
Topics: Aged; Analgesics; Conditioning, Psychological; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Pain Threshold; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2012 |
Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalin.
Topics: Adult; Aged; Analgesics; Antidepressive Agents; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Pilot Projects; Pregabalin; Thiophenes | 2012 |
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
Topics: Acetaminophen; Adrenergic Uptake Inhibitors; Aged; Analgesics, Non-Narcotic; Diabetic Neuropathies; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Norepinephrine; Pain; Palliative Care; Peripheral Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes; Treatment Outcome | 2006 |
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
Topics: Acetaminophen; Amitriptyline; Analgesics; Carbamazepine; Diabetes Complications; Diabetic Neuropathies; Diclofenac; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Lipids; Male; Meloxicam; Middle Aged; Neuralgia; Pentoxifylline; Selective Serotonin Reuptake Inhibitors; Thiamine; Thiazines; Thiazoles; Thioctic Acid; Thiophenes; Time; Vitamin B 12 | 2007 |
Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Peripheral Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2007 |
71 other study(ies) available for duloxetine hydrochloride and Neuralgia
| Article | Year |
|---|---|
Hyperprolactinemia and galactorrhea with duloxetine in neuropathic pain management.
Topics: Adult; Duloxetine Hydrochloride; Female; Galactorrhea; Humans; Hyperprolactinemia; Neuralgia | 2021 |
Risk of Pregabalin-Induced Hypoglycemia: Analysis of the Japanese Adverse Drug Event Report Database.
Topics: Aged; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Gabapentin; Humans; Hypoglycemia; Japan; Neuralgia; Pregabalin | 2022 |
Participation of transient receptor potential vanilloid 1 in the analgesic effect of duloxetine for paclitaxel induced peripheral neuropathic pain.
Topics: Analgesics; Animals; Antineoplastic Agents; Calcitonin Gene-Related Peptide; Duloxetine Hydrochloride; Ganglia, Spinal; Hyperalgesia; Neuralgia; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats; Spinal Cord Dorsal Horn; Substance P; TRPV Cation Channels; Tumor Necrosis Factor-alpha | 2022 |
Symptom-based pharmacotherapy for neuropathic pain related to spinal disorders: results from a patient-based assessment.
Topics: Analgesics; Cauda Equina Syndrome; Duloxetine Hydrochloride; Humans; Musculoskeletal Pain; Neuralgia; Pain Measurement; Paresthesia; Retrospective Studies; Spinal Diseases | 2022 |
Hyponatremia with Antidepressant: A Rare Side Effect from Duloxetine in a Child with Acute Leukemia.
Topics: Antineoplastic Agents; Child; Duloxetine Hydrochloride; Humans; Leukemia; Neuralgia | 2022 |
Duloxetine alleviates oxaliplatin-induced peripheral neuropathy by regulating p53-mediated apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Duloxetine Hydrochloride; Ganglia, Spinal; Mice; Neuralgia; Oxaliplatin; Rats; RNA, Messenger; Tumor Suppressor Protein p53 | 2022 |
Botulinum toxin A for management of refractory concurrent buccal and inferior alveolar nerve post-traumatic neuropathies: a case report.
Topics: Amitriptyline; Animals; Botulinum Toxins, Type A; Carbamazepine; Clonazepam; Duloxetine Hydrochloride; Humans; Mandibular Nerve; Neuralgia; Pregabalin; Quality of Life; Venlafaxine Hydrochloride | 2022 |
Response profile in a rat model of exercise-induced hypoalgesia is associated with duloxetine, pregabalin and diclofenac effect on constriction-induced neuropathy.
Topics: Analgesics; Animals; Constriction, Pathologic; Diclofenac; Duloxetine Hydrochloride; Neuralgia; Pain Threshold; Peripheral Nerve Injuries; Pregabalin; Rats | 2023 |
Analgesic Medication in Fibromyalgia Patients: A Cross-Sectional Study.
Topics: Acetaminophen; Amitriptyline; Analgesics; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cross-Sectional Studies; Dipyrone; Duloxetine Hydrochloride; Fibromyalgia; Humans; Neuralgia; Pregabalin; Selective Serotonin Reuptake Inhibitors | 2022 |
Identification of Spinal Inhibitory Interneurons Required for Attenuating Effect of Duloxetine on Neuropathic Allodynia-like Signs in Rats.
Topics: Analgesics; Animals; Duloxetine Hydrochloride; Hyperalgesia; Interneurons; Neuralgia; Rats | 2022 |
Duloxetine and Amitriptyline Reduce Neuropathic Pain by Inhibiting Primary Sensory Input to Spinal Dorsal Horn Neurons via α1- and α2-Adrenergic Receptors.
Topics: Amitriptyline; Analgesics; Animals; Antidepressive Agents; Duloxetine Hydrochloride; Hyperalgesia; Neuralgia; Norepinephrine; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Spinal Cord Dorsal Horn; Yohimbine | 2023 |
Rosuvastatin Synergistically Enhances the Antinociceptive Efficacy of Duloxetine in Paclitaxel-Induced Neuropathic Pain in Mice.
Topics: Analgesics; Animals; Duloxetine Hydrochloride; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperalgesia; Mice; Neuralgia; Paclitaxel; Pain Measurement; Rosuvastatin Calcium | 2023 |
Treatment-induced neuropathy of diabetes: challenges in diagnosing neuropathic pain, value of sudomotor function testing.
Topics: Analgesics; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neuralgia | 2023 |
Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents.
Topics: Adenosine A3 Receptor Antagonists; Analgesics, Opioid; Animals; Antineoplastic Agents; Bortezomib; Duloxetine Hydrochloride; Female; Fingolimod Hydrochloride; Male; Morphine; Neuralgia; Oxaliplatin; Paclitaxel; Rats; Receptor, Adenosine A3; Sex Factors; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors; Spinal Cord Dorsal Horn | 2020 |
Effectiveness of Pregabalin Compared to Duloxetine in Diabetic Peripheral Neuropathic Pain: An Observational Study.
Topics: Adult; Analgesics; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neuralgia; Pregabalin; Prospective Studies; Treatment Outcome | 2019 |
Common transcriptional signatures of neuropathic pain.
Topics: Duloxetine Hydrochloride; Ganglia, Spinal; Humans; Neuralgia; Nociceptors; Signal Transduction | 2020 |
Behavioral, Electrophysiological, and Histological Characterization of a New Rat Model for Neoadjuvant Chemotherapy-Induced Neuropathic Pain: Therapeutic Potential of Duloxetine and Allopregnanolone Concomitant Treatment.
Topics: Analgesics; Animals; Antineoplastic Agents; Disease Models, Animal; Docetaxel; Duloxetine Hydrochloride; Epirubicin; Female; Neoadjuvant Therapy; Neuralgia; Pain; Pain Measurement; Peripheral Nervous System Diseases; Pregnanolone; Sciatic Nerve | 2020 |
Duloxetine ameliorates the impairment of diffuse noxious inhibitory control in rat models of peripheral neuropathic pain and knee osteoarthritis pain.
Topics: Analgesics; Animals; Chronic Pain; Diffuse Noxious Inhibitory Control; Duloxetine Hydrochloride; Male; Neuralgia; Osteoarthritis, Knee; Pain Measurement; Pregabalin; Rats, Sprague-Dawley | 2020 |
Successful Reversal of Opioid-Induced Hyperalgesia and Allodynia with Duloxetine.
Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Duloxetine Hydrochloride; Humans; Hyperalgesia; Morphine; Neuralgia | 2021 |
Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain.
Topics: Analgesics; Animals; Bone and Bones; Cancer Pain; Disease Models, Animal; Duloxetine Hydrochloride; Glycine Plasma Membrane Transport Proteins; Hyperalgesia; Male; Neuralgia; Pain Measurement; Pain Threshold; Pregabalin; Prostatic Neoplasms; Rats; Rats, Wistar | 2020 |
Pharmacokinetic and pharmacodynamic evaluation of Solid self-nanoemulsifying delivery system (SSNEDDS) loaded with curcumin and duloxetine in attenuation of neuropathic pain in rats.
Topics: Administration, Oral; Animals; Curcumin; Drug Delivery Systems; Duloxetine Hydrochloride; Emulsions; Male; Neuralgia; Particle Size; Rats; Rats, Wistar; Solubility | 2021 |
Differences in the antinociceptive effects of serotonin-noradrenaline reuptake inhibitors via sodium channel blockade using the veratrine test in mice.
Topics: Animals; Behavior, Animal; Duloxetine Hydrochloride; Hyperalgesia; Mice; Neuralgia; Pain Measurement; Serotonin and Noradrenaline Reuptake Inhibitors; Sodium Channel Blockers; Venlafaxine Hydrochloride | 2021 |
Chronic Pain Produces Reversible Memory Deficits That Depend on Task Difficulty in Rats.
Topics: Animals; Chronic Pain; Cognitive Dysfunction; Disease Models, Animal; Duloxetine Hydrochloride; Male; Neuralgia; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Serotonin and Noradrenaline Reuptake Inhibitors | 2021 |
The Microglial Activation Inhibitor Minocycline, Used Alone and in Combination with Duloxetine, Attenuates Pain Caused by Oxaliplatin in Mice.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Behavior, Animal; Disease Models, Animal; Drug Combinations; Duloxetine Hydrochloride; Male; Mice; Microglia; Minocycline; Neuralgia; Oxaliplatin; Pain Threshold | 2021 |
Investigation of the Combination of Pregabalin with Duloxetine or Amitriptyline on the Pharmacokinetics and Antiallodynic Effect During Neuropathic Pain in Rats.
Topics: Amitriptyline; Analgesics; Animals; Disease Models, Animal; Duloxetine Hydrochloride; Hyperalgesia; Male; Neuralgia; Pain Measurement; Pregabalin; Rats; Rats, Wistar | 2021 |
Application of PLGA nanoparticles to enhance the action of duloxetine on microglia in neuropathic pain.
Topics: Animals; Duloxetine Hydrochloride; Humans; Microglia; Nanoparticles; Neuralgia; Rats; Rats, Sprague-Dawley | 2021 |
Spinal dopaminergic involvement in the antihyperalgesic effect of antidepressants in a rat model of neuropathic pain.
Topics: Amitriptyline; Analgesics; Animals; Antidepressive Agents; Cyclopropanes; Disease Models, Animal; Dopamine; Dopamine Antagonists; Duloxetine Hydrochloride; Fluoxetine; Hyperalgesia; Male; Milnacipran; Neuralgia; Pain Threshold; Rats, Sprague-Dawley; Spinal Cord Dorsal Horn; Sulpiride | 2017 |
Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe - the role of the lidocaine 5% medicated plaster.
Topics: Aged; Aged, 80 and over; Amines; Anesthetics, Local; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Europe; Female; Gabapentin; gamma-Aminobutyric Acid; General Practice; Humans; Lidocaine; Male; Middle Aged; Neuralgia; Pregabalin; Retrospective Studies; Treatment Outcome | 2017 |
Repeated Administration of Duloxetine Suppresses Neuropathic Pain by Accumulating Effects of Noradrenaline in the Spinal Cord.
Topics: Analgesics; Animals; Drug Administration Schedule; Duloxetine Hydrochloride; Injections, Subcutaneous; Male; Microdialysis; Neuralgia; Norepinephrine; Pain Measurement; Rats; Rats, Sprague-Dawley; Spinal Cord | 2018 |
Effects of duloxetine on pain and walking distance in neuropathic pain models via modulation of the spinal monoamine system.
Topics: Analgesics; Animals; Biogenic Monoamines; Duloxetine Hydrochloride; Male; Neuralgia; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Compression; Walking | 2018 |
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin.
Topics: Administration, Oral; Animals; Disease Models, Animal; Duloxetine Hydrochloride; Fluorouracil; Humans; Imidazoles; Neuralgia; Pregabalin; Pyrroles; Rats; Rats, Sprague-Dawley | 2017 |
Duloxetine Protects against Oxaliplatin-Induced Neuropathic Pain and Spinal Neuron Hyperexcitability in Rodents.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Duloxetine Hydrochloride; Male; Mice; Mice, Inbred C57BL; Neuralgia; Neurons; Organoplatinum Compounds; Oxaliplatin; Rats; Rats, Sprague-Dawley; Spinal Cord | 2017 |
Altered cerebral blood flow in the anterior cingulate cortex is associated with neuropathic pain.
Topics: Analgesics; Cerebrovascular Circulation; Duloxetine Hydrochloride; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Neuralgia; Pain Measurement; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2018 |
Neuroprotective effect of duloxetine in a mouse model of diabetic neuropathy: Role of glia suppressing mechanisms.
Topics: Animals; Antidepressive Agents; Astrocytes; CD11b Antigen; Diabetic Neuropathies; Duloxetine Hydrochloride; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Male; Mice; Neuralgia; Neuroglia; Neuroprotective Agents; Pain Measurement; Sciatic Nerve; Serotonin Syndrome; Spinal Cord; Spine | 2018 |
Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysis.
Topics: Aged; Aged, 80 and over; Analgesics; Clinical Trials as Topic; Double-Blind Method; Duloxetine Hydrochloride; Exercise; Female; Gabapentin; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Pregabalin; Treatment Outcome | 2018 |
Autonomic Dysreflexia as a Potential Adverse Effect of Duloxetine and Amitriptyline Combination Therapy: A Case Report.
Topics: Adult; Amitriptyline; Analgesics; Autonomic Dysreflexia; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Neuralgia; Spinal Cord Injuries | 2019 |
Peripheral delta opioid receptors mediate duloxetine antiallodynic effect in a mouse model of neuropathic pain.
Topics: Animals; Antidepressive Agents, Tricyclic; Disease Models, Animal; Duloxetine Hydrochloride; Female; Ganglia, Spinal; Hyperalgesia; Male; Mice, Transgenic; Neuralgia; Nortriptyline; Pain Measurement; Receptors, Opioid, delta; Sciatic Nerve | 2018 |
A Dual Noradrenergic Mechanism for the Relief of Neuropathic Allodynia by the Antidepressant Drugs Duloxetine and Amitriptyline.
Topics: Adult; Aged; Amitriptyline; Animals; Antidepressive Agents; Duloxetine Hydrochloride; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Neuralgia; Norepinephrine; Pain Management; Receptor, Adenosine A2A | 2018 |
Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional survey.
Topics: Adjuvants, Pharmaceutic; Adult; Analgesics; Analgesics, Opioid; Attitude of Health Personnel; Cancer Pain; Cross-Sectional Studies; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Japan; Male; Middle Aged; Neuralgia; Palliative Care; Physicians; Pregabalin; Specialization; Surveys and Questionnaires | 2019 |
Distinguishing analgesic drugs from non-analgesic drugs based on brain activation in macaques with oxaliplatin-induced neuropathic pain.
Topics: Analgesics; Animals; Antineoplastic Agents; Brain; Cerebral Cortex; Cryopyrin-Associated Periodic Syndromes; Disease Models, Animal; Duloxetine Hydrochloride; Macaca fascicularis; Magnetic Resonance Imaging; Male; Neuralgia; Oxaliplatin; Pregabalin; Somatosensory Cortex; Tramadol | 2019 |
A three-pronged formulation approach to improve oral bioavailability and therapeutic efficacy of two lipophilic drugs with gastric lability.
Topics: Analgesics; Animals; Biological Availability; Cold Temperature; Curcumin; Drug Carriers; Duloxetine Hydrochloride; Excipients; Gastric Mucosa; Glutathione; Hot Temperature; Hyperalgesia; Muscle, Skeletal; Neuralgia; Peroxidase; Rats; Sciatic Nerve; Touch; Treatment Outcome; Tumor Necrosis Factor-alpha | 2019 |
Opioid and noradrenergic contributions of tapentadol in experimental neuropathic pain.
Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Duloxetine Hydrochloride; Male; Morphine; Neuralgia; Norepinephrine; Pain Measurement; Phenols; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Spinal Nerves; Tapentadol; Thiophenes | 2014 |
Commentary on: Opioid and noradrenergic contributions of tapentadol in experimental neuropathic pain.
Topics: Analgesics, Opioid; Animals; Duloxetine Hydrochloride; Male; Morphine; Neuralgia; Phenols; Spinal Nerves; Tapentadol; Thiophenes | 2014 |
Can topical duloxetine be used for neuropathic pain?
Topics: Administration, Topical; Analgesia; Analgesics; Animals; Duloxetine Hydrochloride; Humans; Models, Theoretical; Neuralgia; Rats; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2014 |
AS1069562, the (+)-isomer of indeloxazine, exerts analgesic effects in a rat model of neuropathic pain with unique characteristics in spinal monoamine turnover.
Topics: Amitriptyline; Analgesics; Animals; Biogenic Monoamines; Dopamine; Dopamine Plasma Membrane Transport Proteins; Duloxetine Hydrochloride; Gastric Emptying; HEK293 Cells; Humans; Male; Morpholines; Motor Activity; Neuralgia; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Spinal Cord; Stereoisomerism; Thiophenes | 2014 |
Antinociceptive effects of AS1069562, the (+)-isomer of indeloxazine, on spinal hypersensitivity induced by intrathecal injection of prostaglandin in mice: comparison with duloxetine and amitriptyline.
Topics: Amitriptyline; Analgesics; Animals; Antidepressive Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Hyperalgesia; Injections, Spinal; Male; Mice, Inbred ICR; Morpholines; Neuralgia; Prostaglandins; Spinal Cord; Stereoisomerism; Thiophenes | 2014 |
Face-to-face comparison of the predictive validity of two models of neuropathic pain in the rat: analgesic activity of pregabalin, tramadol and duloxetine.
Topics: Analgesics; Animals; Cold Temperature; Disease Models, Animal; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Hot Temperature; Hyperalgesia; Male; Neuralgia; Physical Stimulation; Pregabalin; Rats, Wistar; Sciatic Nerve; Thiophenes; Tramadol | 2014 |
ACP Journal Club. Review: In neuropathy, fibromyalgia, or chronic pain, duloxetine reduces pain but increases adverse events.
Topics: Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Neuralgia; Thiophenes | 2014 |
A selective α2 B adrenoceptor agonist (A-1262543) and duloxetine modulate nociceptive neurones in the medial prefrontal cortex, but not in the spinal cord of neuropathic rats.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aniline Compounds; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Electrophysiological Phenomena; HEK293 Cells; Humans; Imidazolines; Male; Neuralgia; Neurons; Nociceptors; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Spinal Cord; Spinal Nerves | 2015 |
Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States.
Topics: Adult; Aged; Amines; Antidepressive Agents; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuralgia; Pregabalin; Quality of Life; Retrospective Studies; Treatment Outcome; United States | 2015 |
The effect of serotonin-noradrenaline reuptake inhibitor duloxetine on the intervertebral disk-related radiculopathy in rats.
Topics: Animals; Brain-Derived Neurotrophic Factor; Duloxetine Hydrochloride; Ganglia, Spinal; Intervertebral Disc Degeneration; Lumbar Vertebrae; Models, Animal; Nerve Growth Factor; Neuralgia; Pain Threshold; Radiculopathy; Rats, Sprague-Dawley; Serotonin and Noradrenaline Reuptake Inhibitors; Tumor Necrosis Factor-alpha | 2016 |
Central Sensitization and Neuropathic Features of Ongoing Pain in a Rat Model of Advanced Osteoarthritis.
Topics: Analgesics; Animals; Arthralgia; Central Nervous System Sensitization; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Hindlimb; Lidocaine; Male; Medulla Oblongata; Neuralgia; Osteoarthritis, Knee; Proto-Oncogene Proteins c-fos; Rats, Sprague-Dawley; Spinal Cord | 2016 |
Role of Collagen Conduit With Duloxetine and/or Pregabalin in the Management of Partial Peripheral Nerve Injury.
Topics: Analgesics; Animals; Collagen; Drug Therapy, Combination; Duloxetine Hydrochloride; Male; Neuralgia; Pain Measurement; Peripheral Nerve Injuries; Pharmaceutical Vehicles; Pregabalin; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2016 |
Duloxetine and 8-OH-DPAT, but not fluoxetine, reduce depression-like behaviour in an animal model of chronic neuropathic pain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Neurons; Analgesics; Animals; Antidepressive Agents; Behavior, Animal; Chronic Disease; Depression; Duloxetine Hydrochloride; Fluoxetine; Hyperalgesia; Male; Neuralgia; Norepinephrine; Rats, Wistar; Serotonergic Neurons; Serotonin | 2016 |
Questions Regarding "Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component".
Topics: Analgesics; Chronic Pain; Duloxetine Hydrochloride; Humans; Low Back Pain; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Thiophenes | 2016 |
Drug combinations in diabetic neuropathic pain: an experimental validation.
Topics: Amitriptyline; Analgesics; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Therapy, Combination; Duloxetine Hydrochloride; Male; Neuralgia; Pain Measurement; Pregabalin; Rats; Rats, Wistar; Sitagliptin Phosphate | 2016 |
Duloxetine Inhibits Microglial P2X4 Receptor Function and Alleviates Neuropathic Pain after Peripheral Nerve Injury.
Topics: Animals; Duloxetine Hydrochloride; Male; Microglia; Neuralgia; Peripheral Nerve Injuries; Purinergic P2X Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P2X4 | 2016 |
Changing general medical practices in the management of neuropathic pain
Topics: Adult; Aged; Amines; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; General Practitioners; Humans; Male; Middle Aged; Neuralgia; Pain Management; Practice Patterns, Physicians'; Pregabalin; Surveys and Questionnaires | 2016 |
Nontricyclic antidepressants for neuropathic pain #187.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Duloxetine Hydrochloride; Humans; Neuralgia; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2009 |
Abnormal gait, due to inflammation but not nerve injury, reflects enhanced nociception in preclinical pain models.
Topics: Amines; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Axotomy; Carrageenan; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Edema; Freund's Adjuvant; Gabapentin; Gait; gamma-Aminobutyric Acid; Hot Temperature; Hyperalgesia; Indomethacin; Inflammation; Male; Morphine; Neuralgia; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Thiophenes | 2009 |
Opioid use and healthcare costs among patients with DPNP initiating duloxetine versus other treatments.
Topics: Adolescent; Adult; Analgesics; Analgesics, Opioid; Case-Control Studies; Cohort Studies; Cost-Benefit Analysis; Duloxetine Hydrochloride; Female; Health Care Costs; Humans; Male; Middle Aged; Neuralgia; Retrospective Studies; Thiophenes; Young Adult | 2010 |
Is duloxetine useful for central neuropathic pain?
Topics: Duloxetine Hydrochloride; Female; Humans; Male; Neuralgia; Spinal Cord Injuries; Stroke; Thiophenes | 2011 |
Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
Topics: Adolescent; Adult; Analgesics; Cohort Studies; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Health Care Costs; Humans; Male; Medication Adherence; Middle Aged; Neuralgia; Pregabalin; Retrospective Studies; Thiophenes; Young Adult | 2011 |
Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain?
Topics: Analgesics; Animals; Antidepressive Agents; Clomipramine; Cyclopropanes; Diabetes Mellitus, Experimental; Disease Models, Animal; Duloxetine Hydrochloride; Hyperalgesia; Male; Milnacipran; Naloxone; Neuralgia; Rats; Rats, Sprague-Dawley; Thiophenes | 2011 |
Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Dopamine Uptake Inhibitors; Duloxetine Hydrochloride; Female; Follow-Up Studies; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuralgia; Pregabalin; Retrospective Studies; Thiophenes; Treatment Outcome | 2011 |
Efficacy, safety and tolerability of duloxetine in idiopathic trigeminal neuralgia.
Topics: Adult; Aged; Aged, 80 and over; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trigeminal Neuralgia | 2011 |
The combined predictive capacity of rat models of algogen-induced and neuropathic hypersensitivity to clinically used analgesics varies with nociceptive endpoint and consideration of locomotor function.
Topics: Amines; Analgesics; Animals; Capsaicin; Cyclohexanecarboxylic Acids; Disease Models, Animal; Duloxetine Hydrochloride; Exploratory Behavior; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Locomotion; Male; Morphine; Neuralgia; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Thiophenes | 2012 |
The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model.
Topics: Administration, Oral; Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Male; Morphine; Neuralgia; Neuroma; Pain Measurement; Pain Threshold; Pregabalin; Rats; Rats, Sprague-Dawley; Thiophenes; Time Factors | 2012 |
Study of emotional and cognitive impairments in mononeuropathic rats: effect of duloxetine and gabapentin.
Topics: Affective Symptoms; Amines; Analgesics; Animals; Antidepressive Agents; Cognition; Cognition Disorders; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duloxetine Hydrochloride; Emotions; Gabapentin; gamma-Aminobutyric Acid; Male; Neuralgia; Rats; Rats, Sprague-Dawley; Thiophenes; Treatment Outcome | 2012 |
Pain treatment for patients with osteoarthritis and central sensitization.
Topics: Brain Mapping; Cognitive Behavioral Therapy; Duloxetine Hydrochloride; Exercise Therapy; Humans; Hyperalgesia; Magnetic Resonance Imaging; Neuralgia; Neuroglia; Nociception; Osteoarthritis; Pain Management; Physical Therapy Modalities; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2013 |
Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Neuralgia; Pain; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes | 2007 |